Abrdn Healthcare Investors
NYSE:HQHAsset Management
+$0.15 today
- Market cap
- $1.27B
- Beta
- 0.76
- P/E (TTM)
- 4.2
- EPS (TTM)
- $4.72
- Dividend yield
- 11.57%
Volume 0.23M
Average 0.14M
HQH Net Income
Bottom-line profit, the starting point for calculating cash from operations.
Abrdn Healthcare InvestorsNYSE: HQH
Net Income · Q4 FY2024 · quarter ended Dec 2024
Net income turns positive
Q4 FY2024 net income was $85.25M, compared with -$26.83M a year earlier. Over 3 fiscal years it compounded at +6.0% a year.
Context
- Net income amounted to 1717.4% of revenue in FY2024, up 1170.0 pp from a year earlier.
- Net income increased in 2 of the last 3 fiscal years.
- FY2024 was the highest annual figure in the 4 fiscal years shown.
Sources:Cash FlowText generated from reported figures; not investment advice.
Net Income history
USD · from the cash flow
- Latest · FY2024
- 184.95M USD
- Year-over-year change
- +228.3%
- 4-year CAGR
- -6.4%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2024 | 2024-12-31 | 184.95M | +228.3% |
| FY2023 | 2023-12-31 | 56.33M | +129.0% |
| FY2022 | 2022-12-31 | (194.23M) | -225.2% |
| FY2021 | 2021-12-31 | 155.18M | -35.7% |
| FY2020 | 2020-12-31 | 241.2M | — |
Net Income vs competitors
How HQH compares with its peers on the latest reported figures
- HQH's FY2024 net income of $184.95M is the largest of the 10 companies compared; the peer median is $88.73M.
- Its year-over-year change of +228.3% is the highest of 10, against a peer median of -13.6%.
- Net income amounts to 1717.4% of revenue for HQH, versus a peer median of 34.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| FY2024 | $184.95M | +228.3% | +6.0% | 1717.4% | |
| LTM Mar 2026 | $167.39M | +30.6% | — | 60.6% | |
| LTM Mar 2026 | $161.43M | +55.7% | -2.1% | 65.9% | |
| LTM Mar 2026 | $114.09M | -20.0% | +8.4% | 14.3% | |
| LTM Mar 2026 | $97.57M | -13.6% | -2.2% | 49.6% | |
KBDCKayne Anderson BDC, Inc. | LTM Mar 2026 | $88.73M | -29.8% | +27.0% | 44.9% |
| LTM Mar 2026 | $61.97M | -8.6% | +167.9% | 34.8% | |
| LTM Mar 2026 | $57.29M | -152.3% | -39.0% | 25.4% | |
| LTM Mar 2026 | $51.15M | -30.7% | -6.5% | 23.6% | |
| LTM Mar 2026 | $23.82M | +166.7% | — | 31.9% | |
| Peer median (excluding HQH) | $88.73M | -13.6% | -2.1% | 34.8% | |
Competitors are the stored peer set for HQH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2020 Dec 2020 | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 |
|---|---|---|---|---|---|
| Net Income | 241.2M | 155.18M | (194.23M) | 56.33M | 184.95M |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 |
| Change in Working Capital | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | (241.2M) | (155.18M) | 194.23M | (56.33M) | (184.95M) |
| Operating Cash Flow | 0 | 0 | 0 | 0 | 0 |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | 0 | 0 | 0 | 0 | 0 |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | 0 | 0 | 0 | 0 | 0 |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 0 | 0 | 0 | 0 | 0 |
| Free Cash Flow | 0 | 0 | 0 | 0 | 0 |
Abrdn Healthcare Investors
NYSE:HQH
Intrinsic Alpha fair value
Locked
Current Price
$22.14
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.